About Us

Founded in 2010 and listed on the SSE STAR Market in 2019, Jiangsu Bioperfectus Technologies Co., Ltd. (“BioPerfectus”, stock code: 688399.SH) is a National High-Tech Enterprise specializing in in vitro diagnostics, medical testing services, and consumer healthcare.

With a focus on infectious disease testing and women’s and children’s health, BioPerfectus has developed more than 700 diagnostic reagents and automated instruments. Its integrated capabilities span key raw materials, laboratory products, and technical services, supporting clinical diagnostics, public health, and at-home testing.

Building on its multiplex real-time PCR and POCT platforms, the company is expanding into digital PCR, mass spectrometry, and next-generation sequencing, while extending its solutions to early cancer screening, respiratory infections, chronic disease management, and nutrition.

BioPerfectus continues to expand globally through its subsidiaries in Hong Kong, Indonesia, the United States, and Brazil. With 549 international market access certifications, its products are available in more than 100 countries and regions worldwide.

Description

Description

Chairman & CEO Message

Dr. Guoqiang Wang

From the very beginning, BioPerfectus has been committed to contributing to our nation through industry and to bringing benefits to society at large. Over the past decade, our company has concentrated on leading the charge in various disease areas, relentlessly pursuing innovation in diagnostic products, and consistently delivering value to patients, families, and healthcare professionals across the globe. Our active participation in major and emergent public health crises has further solidified our dedication to advancing the healthcare system and safeguarding the health of communities worldwide.

Despite the ongoing global health threats posed by infectious diseases and cancer, we are heartened to observe significant progress in combating these complex diseases, thanks to the collective efforts of medical institutions, industry experts, and multidisciplinary partners. Looking ahead, we are filled with passion and confidence, committing ourselves to be a trusted partner in smart testing and disease management for healthcare professionals. We are determined to address the ongoing diagnostic needs of patients and physicians, to contribute to the achievement of the "Healthy China 2030" strategic goals, and to invest our intelligence and energy in securing a healthier future for humanity.